The FDA Adverse Event Monitoring System (AEMS) is FDA's current platform for adverse-event monitoring and related safety workflows. FDA now labels AEMS as the successor terminology to the FDA Adverse Event Reporting System (FAERS).
Why a pharmacovigilance professional uses it
FDA provides AEMS resources for electronic ICSR submissions, public data exploration, quarterly data files and publication of potential safety signals or new safety information.
Search note
Because many historical procedures, internal documents and publications still use the term FAERS, QPPV.com indexes both names. Searching either “AEMS” or “FAERS” will therefore return this resource.